These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22004941)

  • 1. Comparison of SARS and NL63 papain-like protease binding sites and binding site dynamics: inhibitor design implications.
    Chaudhuri R; Tang S; Zhao G; Lu H; Case DA; Johnson ME
    J Mol Biol; 2011 Nov; 414(2):272-88. PubMed ID: 22004941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity.
    Barretto N; Jukneliene D; Ratia K; Chen Z; Mesecar AD; Baker SC
    J Virol; 2005 Dec; 79(24):15189-98. PubMed ID: 16306590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV.
    Lee H; Lei H; Santarsiero BD; Gatuz JL; Cao S; Rice AJ; Patel K; Szypulinski MZ; Ojeda I; Ghosh AK; Johnson ME
    ACS Chem Biol; 2015 Jun; 10(6):1456-65. PubMed ID: 25746232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying structural-functional analogue of GRL0617, the only well-established inhibitor for papain-like protease (PLpro) of SARS-CoV2 from the pool of fungal metabolites using docking and molecular dynamics simulation.
    Rao P; Patel R; Shukla A; Parmar P; Rawal RM; Saraf M; Goswami D
    Mol Divers; 2022 Feb; 26(1):309-329. PubMed ID: 33825097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstruction of the unbinding pathways of new inhibitors of the SARS-CoV-2 papain-like protease using molecular dynamics simulation.
    Rahebi P; Aryapour H
    J Biomol Struct Dyn; 2024 Sep; 42(14):7501-7514. PubMed ID: 37505097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of proton-coupled conformational dynamics of SARS and MERS coronavirus papain-like proteases: Implication for designing broad-spectrum antiviral inhibitors.
    Henderson JA; Verma N; Harris RC; Liu R; Shen J
    J Chem Phys; 2020 Sep; 153(11):115101. PubMed ID: 32962355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme.
    Lindner HA; Fotouhi-Ardakani N; Lytvyn V; Lachance P; Sulea T; Ménard R
    J Virol; 2005 Dec; 79(24):15199-208. PubMed ID: 16306591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbial based natural compounds as potential inhibitors for SARS-CoV-2 Papain-like protease (PLpro): a molecular docking and dynamic simulation study.
    Rahul S; Sarkar A
    J Biomol Struct Dyn; 2022; 40(24):13848-13858. PubMed ID: 34730069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolytic processing and deubiquitinating activity of papain-like proteases of human coronavirus NL63.
    Chen Z; Wang Y; Ratia K; Mesecar AD; Wilkinson KD; Baker SC
    J Virol; 2007 Jun; 81(11):6007-18. PubMed ID: 17392370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of SARS-CoV Covalent Non-Covalent Inhibitors to the SARS-CoV-2 Papain-Like Protease and Ovarian Tumor Domain Deubiquitinases.
    Sivakumar D; Stein M
    Biomolecules; 2021 May; 11(6):. PubMed ID: 34071582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for catalysis and ubiquitin recognition by the severe acute respiratory syndrome coronavirus papain-like protease.
    Chou CY; Lai HY; Chen HY; Cheng SC; Cheng KW; Chou YW
    Acta Crystallogr D Biol Crystallogr; 2014 Feb; 70(Pt 2):572-81. PubMed ID: 24531491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalytic function and substrate specificity of the papain-like protease domain of nsp3 from the Middle East respiratory syndrome coronavirus.
    Báez-Santos YM; Mielech AM; Deng X; Baker S; Mesecar AD
    J Virol; 2014 Nov; 88(21):12511-27. PubMed ID: 25142582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of Main Protease from Human Coronavirus NL63: Insights for Wide Spectrum Anti-Coronavirus Drug Design.
    Wang F; Chen C; Tan W; Yang K; Yang H
    Sci Rep; 2016 Mar; 6():22677. PubMed ID: 26948040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds.
    Báez-Santos YM; St John SE; Mesecar AD
    Antiviral Res; 2015 Mar; 115():21-38. PubMed ID: 25554382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-Based Screening to Discover New Inhibitors for Papain-like Proteinase of SARS-CoV-2: An
    Jamalan M; Barzegari E; Gholami-Borujeni F
    J Proteome Res; 2021 Jan; 20(1):1015-1026. PubMed ID: 33350309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme.
    Ratia K; Saikatendu KS; Santarsiero BD; Barretto N; Baker SC; Stevens RC; Mesecar AD
    Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5717-22. PubMed ID: 16581910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human coronavirus papain-like proteases.
    Báez-Santos YM; Barraza SJ; Wilson MW; Agius MP; Mielech AM; Davis NM; Baker SC; Larsen SD; Mesecar AD
    J Med Chem; 2014 Mar; 57(6):2393-412. PubMed ID: 24568342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papain-like protease 2 (PLP2) from severe acute respiratory syndrome coronavirus (SARS-CoV): expression, purification, characterization, and inhibition.
    Han YS; Chang GG; Juo CG; Lee HJ; Yeh SH; Hsu JT; Chen X
    Biochemistry; 2005 Aug; 44(30):10349-59. PubMed ID: 16042412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMR Characterization of the Papain-like Protease from SARS-CoV-2 Identifies the Conformational Heterogeneity in Its Inhibitor-Binding Site.
    Shiraishi Y; Shimada I
    J Am Chem Soc; 2023 Aug; 145(30):16669-16677. PubMed ID: 37478405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A chimeric virus-mouse model system for evaluating the function and inhibition of papain-like proteases of emerging coronaviruses.
    Deng X; Agnihothram S; Mielech AM; Nichols DB; Wilson MW; StJohn SE; Larsen SD; Mesecar AD; Lenschow DJ; Baric RS; Baker SC
    J Virol; 2014 Oct; 88(20):11825-33. PubMed ID: 25100850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.